Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
This study has been completed.
Sponsor:
TetraLogic Pharmaceuticals
Information provided by (Responsible Party):
TetraLogic Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00993239
First received: October 8, 2009
Last updated: May 21, 2013
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2013 |
| Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |